性别和锚定药物对替诺福韦肾毒性的影响。 - Suppr

The impact of gender and anchor drugs on TDF renal toxicity.

作者信息

Quiros-Roldan Eugenia, Amadasi Silvia, Paraninfo Giuseppe, Izzo Ilaria, Allegri Roberto, Motta Davide, Gatti Francesca, Cristini Graziella, Carosi Giampiero, Mendeni Monia, Torti Carlo

出版信息

J Acquir Immune Defic Syndr. 2010 Oct;55(2):e11-2. doi: 10.1097/QAI.0b013e3181ef7930.

DOI:10.1097/QAI.0b013e3181ef7930

PMID:20859083

Abstract

摘要

相似文献

The impact of gender and anchor drugs on TDF renal toxicity.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):e11-2. doi: 10.1097/QAI.0b013e3181ef7930.

[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].

Med Mal Infect. 2013 Mar;43(3):134-5. doi: 10.1016/j.medmal.2013.01.008. Epub 2013 Feb 20.

Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.

AIDS Patient Care STDS. 2008 Apr;22(4):279-90. doi: 10.1089/apc.2007.0141.

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.

J Acquir Immune Defic Syndr. 2010 Sep;55(1):49-57. doi: 10.1097/QAI.0b013e3181dd911e.

Abacavir/3TC vs. tenofovir/FTC: interim results from ACTG 5202.

AIDS Clin Care. 2008 Apr;20(4):28.

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study.

Antivir Ther. 2013;18(7):905-13. doi: 10.3851/IMP2667. Epub 2013 Jul 31.

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysis.

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):535-40. doi: 10.1097/01.qai.0000245886.51262.67.

Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir.

Antivir Ther. 2011;16(4):459-68. doi: 10.3851/IMP1785.

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):290-7. doi: 10.1097/QAI.0b013e3181aa12d5.

Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine.

PLoS One. 2012;7(6):e38377. doi: 10.1371/journal.pone.0038377. Epub 2012 Jun 15.

引用本文的文献

Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.

Pediatr Infect Dis J. 2013 May;32(5):495-500. doi: 10.1097/INF.0b013e31827f4eff.

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

AIDS. 2012 Sep 24;26(15):1907-15. doi: 10.1097/QAD.0b013e328357f5ed.

Renal issues in HIV infection.

Curr HIV/AIDS Rep. 2011 Sep;8(3):164-71. doi: 10.1007/s11904-011-0080-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The impact of gender and anchor drugs on TDF renal toxicity.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献